Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT00640861 Completed - Breast Cancer Clinical Trials

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Start date: August 28, 2008
Phase: Early Phase 1
Study type: Interventional

RATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. It is not yet known which vaccine is most effective in treating breast cancer. PURPOSE: This randomized clinical trial is studying the side effects of three different vaccine therapies and comparing the vaccines to see how well they work in treating patients with previously treated stage II or stage III breast cancer.

NCT ID: NCT00640666 Completed - Breast Cancer Clinical Trials

Changes in Cancer-related Cytokines After Participation in a Physical Activity Behavior Change Intervention (CICK Study)

CICK
Start date: March 2008
Phase: N/A
Study type: Interventional

It is important to confirm health benefits experienced by breast cancer survivors after participation in a physical activity behavior change intervention. One such potential benefit is a reduction in harmful inflammation that might lead to increased symptoms or cancer risk. Because little is known about how physical activity behavior change interventions influence inflammation in breast cancer survivors, the investigators study will measure inflammation with blood markers known as cytokines among breast cancer survivors before and after a physical activity intervention. Such information has the potential to lead to improved physical functioning, reduction in bothersome symptoms (e.g., fatigue), and reduced cancer risk in breast cancer survivors.

NCT ID: NCT00639366 Completed - Breast Cancer Clinical Trials

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Start date: February 2007
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether radiation therapy directed at the head is effective in preventing brain metastases in patients with advanced cancer. PURPOSE: This randomized phase III trial is studying radiation therapy to the head to see how well it works in preventing brain metastases in women receiving trastuzumab and chemotherapy for metastatic or locally advanced breast cancer.

NCT ID: NCT00639106 Completed - Breast Cancer Clinical Trials

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Start date: March 2008
Phase: Phase 3
Study type: Interventional

Following mastectomy (removal of your breast), reconstruction of your breast(s) can be performed using tissue expanders and implants. At the same operation as your mastectomy, a tissue expander is put under the skin and muscles of your chest. Following your surgery, the tissue expander is gradually filled with salt water over a period of months. Once the expander is filled to the size of your new breast, a second operation is performed. At this time, the tissue expander is removed and a permanent breast implant is placed. This is a standard procedure. We are interested in learning about the use of AlloDerm in breast reconstruction. AlloDerm can be used instead of some of your own chest muscles, in order to cover and protect a tissue expander. We want to know if the use of AlloDerm can decrease your pain or discomfort after surgery and after the filling of your tissue expander. AlloDerm is made from human tissue. When AlloDerm is made all the cells that could cause your body to reject it are removed. When it is placed in your chest, your own cells will then grow into the AlloDerm, causing it to act like the muscle it is replacing. In this study, you will either have reconstruction with AlloDerm or without AlloDerm.

NCT ID: NCT00638599 Completed - Breast Cancer Clinical Trials

Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer

LMATBBC
Start date: January 2008
Phase: Phase 4
Study type: Interventional

Airway management in anesthesia is critical to guarantee appropriate treatment of possible respiratory complications and successful operative practice. LMA® is an alternative to tracheal tube in some surgeries like as mastectomy on breast cancer. Given no need using muscular relaxants in mastectomy, the investigators hypothesized that LMA® would be a superior manner in airway management in radical modified mastectomy on breast cancer than the tracheal tube, and the LMA® might produce less influence on patients' circulatory homeostasis, and easier to be placed before operation.

NCT ID: NCT00638391 Completed - Breast Cancer Clinical Trials

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Ax-003
Start date: May 2005
Phase: N/A
Study type: Observational

The purpose of this study is the initial/followed by 5 year adjuvant therapy with Anastrozole.

NCT ID: NCT00637897 Completed - Breast Cancer Clinical Trials

Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer

Start date: March 2008
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, docetaxel,, paclitaxel, and ixabepilone work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Paricalcitol may help chemotherapy drugs to kill more tumor cells by making tumor cells more sensitive to the drugs. PURPOSE: This clinical trial is studying the best dose and best way to give paricalcitol and to see how well it works when given together with chemotherapy in treating patients with metastatic breast cancer.

NCT ID: NCT00637481 Completed - Breast Cancer Clinical Trials

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Start date: March 2008
Phase: Phase 1
Study type: Interventional

Chemoprevention is the use of certain drugs to keep cancer from forming. The use of atorvastatin (Lipitor) may prevent breast cancer. This randomized phase I trial is studying the best dose of atorvastatin in preventing breast cancer in women at increased risk for breast cancer.

NCT ID: NCT00637026 Completed - Breast Cancer Clinical Trials

Ph II Early BC Pre-Surgical Biologic Study

Start date: July 2003
Phase: Phase 2
Study type: Interventional

A pre-surgery study to assess changes that occur in human breast cancer material and normal skin after a short course of treatment with Iressa.

NCT ID: NCT00636558 Completed - Breast Cancer Clinical Trials

Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)

PSX-X04
Start date: February 29, 2008
Phase: Phase 1
Study type: Interventional

Coxsackie A21 (CVA21) virus is to be administered by IV infusion to patients with Stage 4 melanoma, prostate and breast cancer. This is a dose escalation, safety study.